恩华药业：2025年第三季度归属于上市公司股东的净利润同比增长3.67%

Core Insights - Enhua Pharmaceutical reported a revenue of 1,460,867,102.85 yuan for Q3 2025, representing a year-on-year growth of 5.70% [1] - The net profit attributable to shareholders of the listed company was 405,552,659.33 yuan, showing a year-on-year increase of 3.67% [1]